del.icio.us
Cancer therapy: A role for MAPK inhibitors combined with mTORC1 inhibitorspublished Wed, Aug 20 2008 23:00 GMT
(Beth Israel Deaconess Medical Center) Researchers identify a previously unrecognized problem faced by mTOR inhibitors when it comes to attacking cancers.
Click for more articles from www.eurekalert.org |
|